GMO Small Cap Quality III

GMO Small Cap Quality III

GMAWX
GMO Small Cap Quality IIIUS flagNASDAQ
- -
USD
- -
- -
- -
- -
(- -)

Recent

price

- -

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
GMO Small Cap Quality III (GMAWX) is an institutional mutual fund managed by Grantham, Mayo, Van Otterloo & Co. LLC (GMO), focusing on long-term capital appreciation through investments in high-quality small-cap U.S. equities. The fund employs a quality-oriented strategy that emphasizes companies with strong balance sheets, consistent profitability, high returns on capital, and sustainable competitive advantages; it typically holds a concentrated portfolio of 50-100 stocks selected from the Russell 2000 Index universe, with sector allocations dynamically adjusted based on GMO's proprietary multi-factor models incorporating valuation, profitability, and financial stability metrics. Geographically, it targets U.S.-domiciled small-cap companies operating primarily in North America, serving institutional investors such as endowments, foundations, and pension plans seeking exposure to resilient small-cap segments with lower volatility than traditional benchmarks. Launched in 2016 and based in Boston, Massachusetts, the fund operates as part of GMO's broader asset management platform, which oversees approximately $60 billion in assets across equity, fixed income, and alternative strategies as of late 2025. Recent developments include GMO's strategic expansion into enhanced indexing approaches for small-cap quality in 2024, a key team reinforcement with the addition of experienced portfolio managers specializing in factor investing, and alignment with GMO's firm-wide adoption of advanced ESG integration frameworks announced in early 2025 to better address sustainability risks in small-cap portfolios.